Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults
An adjuvanted vaccine to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) in older adults has recently become available. Post-authorization safety studies (PASSs) conducted under real-world conditions complement data obtained from clinical trials characterized by s...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-06-01
|
| シリーズ: | Vaccine: X |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2590136225000415 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|